@ARTICLE{
author={Schernthaner Guntram,...,Lalic Nebojsa M,...,(broj koautora 17)},
year={2020},
title={Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes},
journal={CARDIOVASCULAR DIABETOLOGY},
volume={19},
number={1},
pages={-},
document_type={Editorial Material},
} 

@ARTICLE{
author={Schernthaner Guntram,...,Lalic Katarina S,...,(broj koautora 17)},
year={2019},
title={Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs},
journal={CARDIOVASCULAR DIABETOLOGY},
volume={18},
number={1},
pages={-},
document_type={Editorial Material},
} 

@ARTICLE{
author={Schernthaner Guntram,Wanner Christoph,Jurisic-Erzen Dubravka,Guja Cristian,Gumprecht Janusz,Jarek-Martynowa Iwona R,Karasik Avraham,Lalic Nebojsa M,Mankovsky Boris N,Prazny Martin,Tankova Tsvetalina,Tsur Anat,Wascher Thomas C,Wittmann Istvan},
year={2019},
title={CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle},
journal={DIABETES RESEARCH AND CLINICAL PRACTICE},
volume={153},
number={},
pages={30-40},
document_type={Editorial Material},
} 

@ARTICLE{
author={Schernthaner Guntram,Drexel Heinz,Moshkovich Evgeny,Zilaitiene Birute,Martinka Emil,Czupryniak Leszek,Varkonyi Tamas,Janez Andrej,Ducena Kristine,Lalic Katarina S,Tankova Tsvetalina,Prazny Martin,Smircic-Duvnjak Lea,Sukhareva Olga,Sourij Harald},
year={2019},
title={SGLT2 inhibitors in T2D and associated comorbidities differentiating within the class},
journal={BMC ENDOCRINE DISORDERS},
volume={19},
number={},
pages={-},
document_type={Letter},
} 

@ARTICLE{
author={Schernthaner Guntram,...,Lalic Nebojsa M,...,(broj koautora 17)},
year={2018},
title={Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?},
journal={CARDIOVASCULAR DIABETOLOGY},
volume={17},
number={},
pages={-},
document_type={Editorial Material},
}